Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    009: CMC Considerations For In-Human Studies with Drs. Edith Perez & Nathan Ihle

    009: CMC Considerations For In-Human Studies with Drs. Edith Perez & Nathan Ihle

    FromBusiness Of Biotech

    Start listeningView podcast show

    009: CMC Considerations For In-Human Studies with Drs. Edith Perez & Nathan Ihle

    FromBusiness Of Biotech

    ratings:
    Length:
    45 minutes
    Released:
    Sep 21, 2020
    Format:
    Podcast episode

    Description

    Bolt Biotherapeutics CMO Dr. Edith Perez and VP of CMC & Quality Dr. Nathan Ihle bring a unique combination of patient and production process expertise to the table for an enlightening conversation on preparing chemistry, manufacturing, and controls for an IND and ensuing first in-human studies.
    Released:
    Sep 21, 2020
    Format:
    Podcast episode

    Titles in the series (100)

    The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, formerly GE Healthcare Life Sciences.